Ozempic was South Carolina's second most expensive Medicare Part D drug in 2023 at $176 million. Medicare's negotiated price starts in 2027. Here is what that means for you.
Ranked 52nd in prescriptions. But Ozempic is South Carolina's second most expensive Medicare drug.
Ozempic (semaglutide) is a once-weekly injectable for Type 2 diabetes. It belongs to the GLP-1 class and lowers blood sugar while reducing cardiovascular risk in people with existing heart disease. South Carolina's diabetes rate is above the national average, and that disease burden, concentrated in rural and coastal communities, drives high GLP-1 prescribing in the Medicare population.
No generic semaglutide exists. At $1,331 per prescription, SC Medicare spent $175.5 million on 131,880 Ozempic fills in 2023. Metformin costs about $9 per prescription, so Ozempic is roughly 148 times more expensive per fill. Its prescription-volume rank (52nd) and its cost rank (2nd) are 50 positions apart.
Ozempic was picked for the second round of Medicare's price negotiation program under the Inflation Reduction Act. CMS announced a negotiated price of $274 for a 30-day supply of semaglutide, which covers Ozempic, Rybelsus and Wegovy, starting January 1, 2027. The list price CMS compared it with was about $959, so the negotiated price is roughly 71% lower.
That $274 is what Medicare will pay, not a new copay. Your Part D plan still sets your deductible, tier and cost sharing, so your actual savings will not be clear until your plan publishes its 2027 benefits. Read your 2027 Annual Notice of Change to see how your plan will treat Ozempic.
| Diabetes drug | Negotiated price takes effect |
|---|---|
| Jardiance, Farxiga | January 1, 2026 |
| Ozempic, Rybelsus, Wegovy | January 1, 2027 |
| Trulicity | Selected for negotiation in January 2026; any price would take effect no earlier than January 1, 2028 |
Ozempic is covered under Part D for Type 2 diabetes. A different, temporary program covers some weight-loss GLP-1s. From July 1, 2026 through December 31, 2027, the CMS Medicare GLP-1 Bridge lets eligible Part D enrollees, in a stand-alone drug plan or a Medicare Advantage plan with drug coverage, get Wegovy (injection and tablets), the KwikPen form of Zepbound and Foundayo for a flat $50 monthly copay. It requires prior authorization from your prescriber, it is processed separately from your Part D plan, and the $50 does not count toward your Part D deductible or out-of-pocket cap. It does not change how Ozempic is covered for diabetes.
Plans vary significantly in how they tier Ozempic. Part D caps what you pay out of pocket for covered drugs at $2,100 in 2026 and $2,400 in 2027, and the Medicare Prescription Payment Plan can spread costs into monthly payments. If your income is limited, Extra Help (the Part D Low-Income Subsidy) can reduce your cost sharing. You can check eligibility at ssa.gov, and our guide to South Carolina Medicare Savings Programs lists the 2026 Extra Help limits.
SC Medicare spent roughly $550 million on GLP-1 drugs and SGLT2 inhibitors combined in 2023. Ozempic, Jardiance, Trulicity and Farxiga alone account for nearly that entire amount. Diabetes is the most expensive therapeutic category in South Carolina Medicare Part D.
Skyler Abilla is a licensed Medicare agent serving the Lowcountry. Bring your medication list and we will check each drug against every plan available at your address. Call (843) 284-6815 or book a free call.
Source: CMS Medicare Part D Prescribers by Geography and Drug, 2023 (South Carolina). Negotiated prices: CMS Medicare Drug Price Negotiation Program, as reported by NBC News (November 2025) and NCPA (December 2025). Third-cycle drug list: CMS press release, January 27, 2026. GLP-1 Bridge: CMS program details as summarized by NFP (June 10, 2026). Part D 2027 cap: CMS CY 2027 Rate Announcement (April 2026).
Tell us a little about you and a licensed Abilla Advisors agent will call you. No cost, no obligation.
We do not offer every plan available in your area. To get information on all of your options, contact Medicare.gov, 1-800-MEDICARE, or your local State Health Insurance Assistance Program (SHIP).
Get personalized Medicare guidance with no cost and no obligation.